新股消息 | 百普赛斯(301080.SZ)递表港交所

Group 1 - The core point of the article is that Beijing Baipusi Biotechnology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CMB International as its sole sponsor [1] - Baipusi is a global provider of life science tools and technology services, focusing on empowering biopharmaceutical companies across the entire value chain of research and development, production, and clinical applications [1] - According to Frost & Sullivan, Baipusi ranks first among all domestic suppliers in China and third globally in the recombinant protein market based on revenue projected for 2024 [1]